Phase II trial planned for Aphton's antigastrin-targeted therapy in lung cancer patients Aug. 6, 2001
Phase III trial for HspE7 for anal dysplasia caused by HPV completes enrollment ahead of schedule Aug. 2, 2001
High proportion of complete remissions obtained in hairy cell leukemia with new immunotoxin July 30, 2001
RSS